收费全文 | 1075篇 |
免费 | 99篇 |
国内免费 | 2篇 |
耳鼻咽喉 | 2篇 |
儿科学 | 59篇 |
妇产科学 | 37篇 |
基础医学 | 181篇 |
口腔科学 | 22篇 |
临床医学 | 205篇 |
内科学 | 153篇 |
皮肤病学 | 4篇 |
神经病学 | 41篇 |
特种医学 | 75篇 |
外科学 | 87篇 |
综合类 | 9篇 |
预防医学 | 193篇 |
眼科学 | 11篇 |
药学 | 48篇 |
肿瘤学 | 49篇 |
2024年 | 2篇 |
2023年 | 7篇 |
2022年 | 13篇 |
2021年 | 24篇 |
2020年 | 19篇 |
2019年 | 32篇 |
2018年 | 51篇 |
2017年 | 33篇 |
2016年 | 38篇 |
2015年 | 32篇 |
2014年 | 39篇 |
2013年 | 58篇 |
2012年 | 79篇 |
2011年 | 72篇 |
2010年 | 48篇 |
2009年 | 48篇 |
2008年 | 58篇 |
2007年 | 86篇 |
2006年 | 45篇 |
2005年 | 62篇 |
2004年 | 72篇 |
2003年 | 56篇 |
2002年 | 57篇 |
2001年 | 7篇 |
2000年 | 9篇 |
1999年 | 11篇 |
1998年 | 18篇 |
1997年 | 12篇 |
1996年 | 7篇 |
1995年 | 12篇 |
1994年 | 4篇 |
1993年 | 4篇 |
1992年 | 4篇 |
1991年 | 5篇 |
1990年 | 3篇 |
1989年 | 5篇 |
1987年 | 3篇 |
1985年 | 2篇 |
1983年 | 5篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1977年 | 2篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1971年 | 2篇 |
1970年 | 1篇 |
1969年 | 2篇 |
1965年 | 1篇 |
1954年 | 1篇 |
Background
Although self-tests are increasingly available and widely used, it is not clear whether their use is beneficial to the users, and little is known concerning the determinants of self-test use. The aim of this study was to identify the determinants of self-test use for cholesterol, glucose, and HIV, and to examine whether these are similar across these tests. Self-testing was defined as using in-vitro tests on body materials, initiated by consumers with the aim of diagnosing a particular disorder, condition, or risk factor for disease. 相似文献Background
Patients with type 2 diabetes mellitus (T2DM) have an increased risk to develop severe diabetes related complications, especially cardiovascular disease (CVD). The risk to develop CVD can be estimated by means of risk formulas. However, patients have difficulties to understand the outcomes of these formulas. As a result, they may not recognize the importance of changing lifestyle and taking medication in time. Therefore, it is important to develop risk communication methods, that will improve the patients' understanding of risks associated with having diabetes, which enables them to make informed choices about their diabetes care. 相似文献Background
Self-tests are available to consumers for more than 25 conditions, ranging from infectious diseases to cardiovascular risk factors. Self-tests are defined as in-vitro tests on body materials such as blood, urine, faeces, or saliva that are initiated by consumers to diagnose a particular disorder or risk factor without involving a medical professional. In 2006, 16% of a sample of Dutch Internet users had ever used at least one self-test and 17% intended to use a self-test in the future. The objectives of this study are to determine (1) the frequency of self-test use, (2) the consumers' reasons for using or not using a self-test, (3) the information that is used by self-testers in the different self-test stages and the consumers' interpretation of the quality of this information, (4) the consumers' response to self-test results in terms of their confidence in the result, reassurance by the test result, and follow-up behaviour, (5) the information consumers report to need in the decision making process of using or not using a self-test, and in further management on the basis of the self-test result, and (6) the quality of the currently available consumer information on a selected set of self-tests. 相似文献Background Insulin is a high-risk medicine, associated with hospital medication errors. Pharmacists play an important role in the monitoring of patients on insulin.
Objective To analyse interventions made by hospital pharmacists that were associated with insulin prescribing for inpatients with diabetes.
Method Retrospective audit of pharmacist interventions for adult inpatients for an 8-month period, 1 June 2019–31 January 2020. Pharmacist interventions recorded in the electronic medication management system by inpatient unit and dedicated high-risk medicine pharmacists were extracted, screened, and analysed.
Results Of 3975 pharmacist interventions 3356 (84.43%) were recorded by high-risk medicine pharmacists and 619 (15.57%) by inpatient unit pharmacists. July and August 2019 had the highest numbers of interventions with 628 and 643 (15.80 and 16.18%) respectively. Most of the interventions, namely 3410 (85.79%) were classified as medicine optimisation interventions and 565 (14.21%) as prescribing errors. In the medicine optimisation intervention category, 2985 (75.09%) were due to insulin not charted for ongoing administration.
Conclusion This study provides insights into pharmacist interventions for inpatients on insulin, showing that high-risk medicine pharmacists recorded most interventions. The classification of the insulin interventions into medicine optimisation and prescribing errors provides useful information for the training of prescribers in insulin management.
相似文献